S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
Stock market today: Wall Street rises in premarket as bond markets stabilize and earnings roll in
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
United Airlines Soars on Earnings Beat
CSX profit drops 10% despite railroad delivering 3% more freight in first quarter
These are the Top 4 Stocks for Buybacks in 2024
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
Stock market today: Wall Street rises in premarket as bond markets stabilize and earnings roll in
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
United Airlines Soars on Earnings Beat
CSX profit drops 10% despite railroad delivering 3% more freight in first quarter
These are the Top 4 Stocks for Buybacks in 2024
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
Stock market today: Wall Street rises in premarket as bond markets stabilize and earnings roll in
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
United Airlines Soars on Earnings Beat
CSX profit drops 10% despite railroad delivering 3% more freight in first quarter
These are the Top 4 Stocks for Buybacks in 2024
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
Stock market today: Wall Street rises in premarket as bond markets stabilize and earnings roll in
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
United Airlines Soars on Earnings Beat
CSX profit drops 10% despite railroad delivering 3% more freight in first quarter
These are the Top 4 Stocks for Buybacks in 2024
CVE:MPH

Medicure (MPH) Stock Price, News & Analysis

C$1.08
+0.02 (+1.89%)
(As of 04/17/2024 05:33 PM ET)
Today's Range
C$1.08
C$1.08
50-Day Range
C$1.04
C$1.37
52-Week Range
C$1.00
C$1.80
Volume
260 shs
Average Volume
4,051 shs
Market Capitalization
C$11.07 million
P/E Ratio
12.00
Dividend Yield
2.24%
Price Target
N/A
MPH stock logo

About Medicure Stock (CVE:MPH)

Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company offers Sodium Nitroprusside injection for the reduction of blood pressure for adult and pediatric patients in hypertensive crisis, as well as for producing controlled hypotension to reduce bleeding during surgery, and for the treatment of acute congestive heart failure. It offers products through retail and mail order pharmacies. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada.

MPH Stock Price History

MPH Stock News Headlines

IRS Loophole Gives Americans An Escape From Inflation
In the years immediately following 2008-09, as the economy stagnated, gold exploded in value. Today, Goldman Sachs is telling its clients that gold may reach $2,250 within the next few years. Don't miss your chance to diversify your savings.
IRS Loophole Gives Americans An Escape From Inflation
In the years immediately following 2008-09, as the economy stagnated, gold exploded in value. Today, Goldman Sachs is telling its clients that gold may reach $2,250 within the next few years. Don't miss your chance to diversify your savings.
Charing - Weather warnings issued
Portishead - Weather warnings issued
Chelmsford - Weather warnings issued
Redruth - Weather warnings issued
Leven - Weather warnings issued
Gravesend - Weather warnings issued
See More Headlines
Receive MPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medicure and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/24/2017
Today
4/18/2024
Next Earnings (Estimated)
5/24/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
C$1.08 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$22.94 million
Cash Flow
C$0.43 per share
Book Value
C$2.10 per share

Miscellaneous

Free Float
N/A
Market Cap
C$11.07 million
Optionable
Not Optionable
Beta
1.01
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Dr. Albert David Friesen Ph.D. (Age 77)
    Founder, CEO & Chairman of the board
    Comp: $237.6k
  • Dr. Neil Owens Ph.D.
    President & COO
  • Mr. Haaris Uddin B.Com.
    CPA, Chief Financial Officer
  • Dr. Reuben Saba Ph.D.
    Vice President of Scientific & Medical Affairs

MPH Stock Analysis - Frequently Asked Questions

How have MPH shares performed in 2024?

Medicure's stock was trading at C$1.40 at the start of the year. Since then, MPH shares have decreased by 22.9% and is now trading at C$1.08.
View the best growth stocks for 2024 here
.

When is Medicure's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, May 24th 2024.
View our MPH earnings forecast
.

How were Medicure's earnings last quarter?

Medicure Inc. (CVE:MPH) posted its quarterly earnings results on Wednesday, May, 24th. The company reported ($0.33) EPS for the quarter, missing the consensus estimate of $0.04 by $0.37. The firm had revenue of $8.71 million for the quarter, compared to analysts' expectations of $14.50 million. Medicure had a net margin of 4.71% and a trailing twelve-month return on equity of 5.04%.

What other stocks do shareholders of Medicure own?
How do I buy shares of Medicure?

Shares of MPH stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:MPH) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners